Tizanidine
- Product NDC
- 70934-656
- 11-digit product format
- 709340656
- Labeler code
- 70934
- Product ID
- 70934-656_aa6d4621-9bd1-50e0-e053-2a95a90adf18
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2020-06-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-656-15 | 70934065615 | 15 TABLET in 1 BOTTLE, PLASTIC (70934-656-15) | 15 tablet | 2020-06-16 | 0000-00-00 | No | No | Current |